enkephalin, d-penicillamine (2,5)- has been researched along with Pain, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balboni, G; Charfi, I; Mnie-Filali, O; Nagi, K; Pineyro, G; Schiller, PW; Thibault, D; Trudeau, LE | 1 |
1 other study(ies) available for enkephalin, d-penicillamine (2,5)- and Pain, Chronic
Article | Year |
---|---|
Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.
Topics: Analysis of Variance; Benzamides; Benzimidazoles; Blotting, Western; Chronic Pain; Cyclic AMP; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Fluorescent Antibody Technique; G-Protein-Coupled Receptor Kinase 2; Green Fluorescent Proteins; HEK293 Cells; Humans; Ligands; Neurons; Oligopeptides; Piperazines; Receptors, Opioid, delta | 2014 |